Accelerate Diagnostics (AXDX) Expected to Announce Quarterly Earnings on Thursday

Accelerate Diagnostics (NASDAQ:AXDX) is projected to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.46) per share and revenue of $3.00 million for the quarter.

Accelerate Diagnostics Stock Down 1.3 %

AXDX stock opened at $1.12 on Thursday. Accelerate Diagnostics has a 52 week low of $0.73 and a 52 week high of $2.09. The stock has a market capitalization of $27.92 million, a P/E ratio of -0.39 and a beta of 0.55. The firm has a 50-day simple moving average of $1.17 and a 200-day simple moving average of $1.46.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AXDX. StockNews.com began coverage on shares of Accelerate Diagnostics in a research note on Monday. They set a “hold” rating for the company. BTIG Research raised shares of Accelerate Diagnostics to a “strong-buy” rating in a research note on Wednesday, December 11th.

About Accelerate Diagnostics

Accelerate Diagnostics, Inc, an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms.